BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10690134)

  • 1. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early reversal of rapacuronium with neostigmine.
    Purdy R; Bevan DR; Donati F; Lichtor JL
    Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
    Hayes A; Breslin D; Reid J; Mirakhur RK
    Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter evaluation of the time-course of action of two doses of rapacuronium after early and late reversal with neostigmine.
    Larijani GE; Donati F; Bikhazi G; Bartkowski R; Kenaan CA; Plaud B; Goldberg ME
    Anesth Analg; 2001 Aug; 93(2):370-4 , 3rd contents page. PubMed ID: 11473863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of rapacuronium block during propofol versus sevoflurane anesthesia.
    Zhou TJ; Tang J; White PF; Joshi GP; Wender R; Murphy MT; Chiu JW; Webb T
    Anesth Analg; 2000 Mar; 90(3):689-93. PubMed ID: 10702458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium.
    Astley BA; Katz RL; Payne JP
    Br J Anaesth; 1987 Aug; 59(8):983-8. PubMed ID: 2888476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases.
    McCoy EP; Mirakhur RK; Maddineni VR; Loan PB; Connolly F
    Anaesthesia; 1994 Nov; 49(11):940-5. PubMed ID: 7802236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.